HealthcareServices

Hyperimmune Globulins Market Future Outlook: Strong Growth Expected Toward $2.86 Billion by 2030

February 25, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the hyperimmune globulins market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Hyperimmune Globulins Market in 2026, and what figure is it projected to hit by 2030?

The hyperimmune globulins market size has demonstrated robust expansion in recent years. It is forecast to increase from $2.06 billion in 2025 to $2.21 billion in 2026, progressing at a compound annual growth rate (CAGR) of 7.6%. In the historic period, this growth was primarily driven by the established use in rabies and tetanus prophylaxis, an increasing incidence of infectious diseases, a reliance on plasma-derived therapies, government immunization programs, and the growth of hospital-based emergency care.

The hyperimmune globulins market is expected to experience robust growth in the upcoming years. It is predicted to expand to $2.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. This anticipated expansion during the forecast period can be attributed to several factors including an increase in organ transplantation rates, a rise in viral infection outbreaks, the expansion of plasma donation infrastructure, ongoing advancements in purification technologies, and a heightened emphasis on achieving rapid immune protection. Key trends foreseen in this period encompass a growing demand for passive immunization therapies, broader application in post-exposure prophylaxis, increased utilization in transplant and immunocompromised patient care, the enlargement of plasma collection and fractionation capacities, and the reinforcement of regulatory oversight and quality standards.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16448&type=smp

Which Drivers Are Affecting Market Participation In The Hyperimmune Globulins Market?

The projected expansion of the hyperimmune globulin market is linked to the growing occurrence of infectious diseases. These illnesses stem from harmful agents or pathogens, such as viruses, bacteria, fungi, and parasites, entering the body. The rise in infectious diseases can be attributed to factors like antimicrobial resistance, climate change, and population growth. Hyperimmune globulins are employed in managing infectious diseases to deliver immediate passive immunity through concentrated antibodies targeting specific pathogens, thereby aiding in the prevention or treatment of conditions such as rabies, hepatitis B, or tetanus. For example, a report from the UK Health Security Agency in August 2024 indicated that in 2023, the West Midlands region accounted for the highest number of measles cases, with 160 cases (44%), closely followed by London with 122 cases (33%). It was noted that children under the age of 10 comprised 63% of the total cases, amounting to 232 cases. Measles activity saw a notable increase towards the end of the year, with 157 new cases registered in December, compared to just 45 cases in November. Consequently, the increasing prevalence of infectious diseases is a key factor driving the growth of the hyperimmune globulin market. Government-led initiatives for research and development within the healthcare sector are anticipated to fuel the expansion of the hyperimmune globulins market moving forward. Such initiatives are increasing due to the heightened demand for innovative medical solutions and the necessity to address evolving health challenges. These governmental efforts facilitate the creation and accessibility of hyperimmune globulins, enabling effective combat against particular infectious diseases. As an illustration, the Office for National Statistics, a UK government department, reported in May 2024 that total healthcare expenditure experienced a 5.6% increase in nominal terms between 2022 and 2023, marking a significant acceleration when compared to the 0.9% growth observed in 2022. Hence, the escalating government initiatives for healthcare research and development are propelling the hyperimmune globulins market.

What Segment Categories Are Covered In The Hyperimmune Globulins Market?

The hyperimmune globulins market covered in this report is segmented –

1) By Type: Hepatitis B Hyperimmune Globulin, Rabies Hyperimmune Globulin, Tetanus Hyperimmune Globulin, Cytomegalovirus (CMV) Hyperimmune Globulin, Varicella-Zoster Virus (VZV) Hyperimmune Globulin, Respiratory Syncytial Virus (RSV) Hyperimmune Globulin, Other Types

2) By Route Of Administration: Intramuscular, Intravenous

3) By Application: Government Institution, Private Sector, Other Applications

Subsegments:

1) By Hepatitis B Hyperimmune Globulin: Intramuscular Hepatitis B Hyperimmune Globulin, Intravenous Hepatitis B Hyperimmune Globulin

2) By Rabies Hyperimmune Globulin: Rabies Immune Globulin (Human), Rabies Immune Globulin (Equine)

3) By Tetanus Hyperimmune Globulin: Tetanus Immune Globulin (Human), Tetanus Immune Globulin (Equine)

4) By Cytomegalovirus (Cmv) Hyperimmune Globulin: Cmv Immune Globulin For Organ Transplantation, Cmv Immune Globulin For Neonatal Infection

5) By Varicella-Zoster Virus (Vzv) Hyperimmune Globulin: Vzv Immune Globulin For Post-Exposure Prophylaxis, Vzv Immune Globulin For Immunocompromised Patients

6) By Respiratory Syncytial Virus (Rsv) Hyperimmune Globulin: Rsv Immune Globulin For Infants And Children, Rsv Immune Globulin For Adults With Respiratory Conditions

7) By Other Types: Diphtheria Hyperimmune Globulin, Botulism Hyperimmune Globulin, Other Specialized Hyperimmune Globulins

Which Key Market Players Are Investing In Expansion And Innovation Within The Hyperimmune Globulins Market?

Major companies operating in the hyperimmune globulins market are Bayer AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Ltd., Fresenius Kabi AG, Grifols SA, Octapharma AG, Shanghai RAAS Blood Products Co. Ltd., Emergent BioSolutions Inc., Kedrion Biopharma Inc., LFB SA, Hualan Biological Engineering Inc., Taibang Biologic Group, Bio Products Laboratory (BPL) Ltd., ADMA Biologics, Cangene Corporation, Kamada Ltd., Saol Therapeutics Inc., Shire, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report

Which Regions Are Projected To Dominate The Hyperimmune Globulins Market In The Coming Years?

North America was the largest region in the hyperimmune globulins market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperimmune globulins market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hyperimmune Globulins Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16448&type=smp

Browse Through More Reports Similar to the Global Hyperimmune Globulins Market 2026, By The Business Research Company

Subcutaneous Immunoglobulin Scig Market Report 2026

https://www.thebusinessresearchcompany.com/report/subcutaneous-immunoglobulin-scig-global-market-report

Immunoglobulins Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Mammalian Polyclonal Immunoglobulin G Igg Antibody Market Report 2026

https://www.thebusinessresearchcompany.com/report/mammalian-polyclonal-immunoglobulin-g-igg-antibody-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795